TABLE 2.
Substrate and parametera | NDM-1b | Q119C | Q119F | Q119E | Q119Y | Q119V | Q119K |
---|---|---|---|---|---|---|---|
Imipenem | |||||||
kcat (s−1) | 64 | 69 | 336 | 41 | 79 | 229 | 393 |
Km (μM) | 35 | 50 | 157 | 40 | 30 | 65 | 90 |
kcat/Km (μM−1 s−1) | 1.83 | 1.38 | 2.14 | 1.02 | 2.63 | 3.52 | 4.37 |
Meropenem | |||||||
kcat (s−1) | 75 | 252 | 1500 | 82 | 561 | 269 | 357 |
Km (μM) | 80 | 100 | 252 | 146 | 105 | 20 | 37 |
kcat/Km (μM−1 s−1) | 0.94 | 2.52 | 5.95 | 0.56 | 5.34 | 13.45 | 9.65 |
Benzylpenicillin | |||||||
kcat (s−1) | 105 | 100 | 166 | 100 | 34 | 231 | 414 |
Km (μM) | 250 | 71 | 89 | 5c | 8c | 45 | 15 |
kcat/Km (μM−1 s−1) | 0.42 | 1.41 | 1.86 | 20.0 | 4.25 | 5.10 | 27.6 |
Carbenicillin | |||||||
kcat (s−1) | 108 | 52 | 158 | 234 | 216 | 267 | 929 |
Km (μM) | 285 | 59 | 131 | 18 | 31 | 32 | 35 |
kcat/Km (μM−1 s−1) | 0.38 | 0.88 | 1.21 | 13.00 | 6.97 | 8.34 | 26.54 |
Cefazolin | |||||||
kcat (s−1) | 42 | 48 | 169 | 63 | 561 | 269 | 125 |
Km (μM) | 20 | 11 | 27 | 4c | 105 | 20 | 32 |
kcat/Km (μM−1 s−1) | 2.10 | 4.36 | 6.26 | 15.75 | 5.34 | 13.45 | 3.90 |
Cefoxitin | |||||||
kcat (s−1) | 23 | 99 | 152 | 64 | 85 | 193 | 58 |
Km (μM) | 26 | 23 | 21 | 23 | 17 | 18 | 49 |
kcat/Km (μM−1 s−1) | 0.88 | 4.30 | 7.24 | 2.78 | 5.00 | 10.72 | 1.18 |
Cefotaxime | |||||||
kcat (s−1) | 20 | 43 | 59 | 4 | 7 | 21 | 89 |
Km (μM) | 14 | 7c | 6c | 2c | 2c | 10c | 3c |
kcat/Km (μM−1 s−1) | 1.43 | 6.14 | 9.83 | 2.00 | 3.50 | 2.00 | 29.67 |
Ceftazidime | |||||||
kcat (s−1) | 18.5 | 74 | 257 | 14 | 68 | 7 | 106 |
Km (μM) | 50 | 163 | 403 | 140 | 2c | 3c | 11 |
kcat/Km (μM−1 s−1) | 0.37 | 0.45 | 0.64 | 0.10 | 34.00 | 2.33 | 9.64 |
Cefepime | |||||||
kcat (s−1) | 13 | 22 | 67 | 18 | 30 | 71 | 60 |
Km (μM) | 35 | 30 | 16 | 40 | 4c | 10c | 18 |
kcat/Km (μM−1 s−1) | 0.37 | 0.73 | 4.19 | 0.45 | 7.50 | 7.10 | 3.33 |